Axa’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-41,145
Closed -$3.05M 466
2025
Q2
$3.05M Buy
41,145
+5,315
+15% +$370K 0.01% 672
2025
Q1
$2.89M Buy
35,830
+2,460
+7% +$211K 0.01% 663
2024
Q4
$2.61M Sell
33,370
-18,943
-36% -$1.61M 0.01% 702
2024
Q3
$4.91M Buy
52,313
+2,234
+4% +$188K 0.01% 548
2024
Q2
$3.9M Buy
50,079
+2,303
+5% +$188K 0.01% 592
2024
Q1
$4.34M Sell
47,776
-34,266
-42% -$2.85M 0.01% 591
2023
Q4
$6.34M Buy
82,042
+34,255
+72% +$2.4M 0.02% 493
2023
Q3
$3.25M Buy
47,787
+4,219
+10% +$307K 0.01% 619
2023
Q2
$3.54M Sell
43,568
-109,816
-72% -$8.76M 0.01% 626
2023
Q1
$12.6M Buy
+153,384
New +$11M 0.04% 373

Other funds holding GEHC

Axa's GEHC Position: Q3 2025 in Review

Axa sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 41,145 shares — an estimated $3.05M sold.

Axa first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $12.6M in Q1 2023. 1,279 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Axa reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Axa sold 41,145 GE HealthCare shares in Q3 2025, an estimated $3.05M.
  • Axa first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • Axa's GE HealthCare position peaked at $12.6M in Q1 2023.
  • 1,279 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.